Circulating chemerin levels have been shown to be significantly elevated in cancer patients compared to healthy controls, with a pooled standardized mean difference of 1.47 (95% CI: 1.03–1.90), suggesting a strong correlation between high chemerin levels and increased cancer risk [51]. Here, RARRES2 is linked to cancer.